Sapience Therapeutics
NY, New York, United States
Jim Rotolo is the VP of Translational Pharmacology and Head of Research at Sapience Therapeutics, where he is leading the Company's discovery and pre-clinical development efforts. Dr. Rotolo holds a B.S. in Chemistry from Emory University, an M.S. in Pharmacology and Toxicology from Long Island University, and a Ph.D. in Pharmacology and Immunology from the Weill Cornell Graduate School of Medical Sciences and Memorial Sloan-Kettering Cancer Center. His work has resulted in over 20 publications and multiple patents/patent applications.
